Log in
Enquire now
‌

US Patent 7214660 Erythropoietin: remodeling and glycoconjugation of erythropoietin

Patent 7214660 was granted and assigned to Neose Technologies Inc. on May, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Patent abstractTimelineTable: Further ResourcesReferences
Is a
Patent
Patent
1

Patent attributes

Current Assignee
‌
Neose Technologies Inc.
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
72146601
Patent Inventor Names
Shawn DeFrees1
Xi Chen1
Caryn Bowe1
David A. Zopf1
David James Hakes1
Robert J. Bayer1
Date of Patent
May 8, 2007
1
Patent Application Number
104109451
Date Filed
April 9, 2003
1
Patent Citations Received
‌
US Patent 12110338 Site-specific antibody-drug conjugation through glycoengineering
2
Patent Primary Examiner
‌
Cecilia J. Tsang
1
Patent abstract

The invention includes methods and compositions for remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group to a peptide.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7214660 Erythropoietin: remodeling and glycoconjugation of erythropoietin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.